• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

A Wave of New Treatments, a Tsunami of Ultrahigh Prices

MHE PublicationMHE August 2023
Volume 33
Issue 8

Charging more than $2 million for a single treatment was once unthinkable, but no more.

Charging more than $2 million for a single treatment was once unthinkable, but no more. Today’s gene therapies and other innovative medicines for rare diseases come with price tags that stagger the mind, and despite continuing public controversy over drug pricing, they’re not necessarily unfair.

Still, that leaves the question of how a health plan today can absorb even a single claim without looking like the misshapen boa constrictor in “The Little Prince” who famously — and visibly — had swallowed an elephant.

Related: When Drugs Became Ultra-Ultra Expensive

Below are just a few of the recent FDA-approved therapies with staggering price tags.

Source: FDA reports and news accounts.

Source: FDA reports and news accounts.

Related Content
© 2024 MJH Life Sciences

All rights reserved.